Join us at the 12th Annual American Biomanufacturing Summit, taking place at Hyatt Regency San Francisco Airport on 14th-15th April 2026.
The Generis American Biomanufacturing Summit (BIO) has a strong reputation as the leading platform for connecting senior leaders and exchanging ideas in the biopharma and biotech industries. This two-day conference is designed to bring together biopharma executives and solution providers to discuss emerging trends, strategic insights, and best practices in an ever-evolving biomanufacturing landscape. Join over 350 biopharma and biotech executive leaders, including more than 50 speakers, 150 senior-level attendees, and hundreds of participants from solution companies at this annual event as we explore the latest challenges, opportunities, and innovations shaping the industry. With sessions led by top biotech executives, the agenda will dive into critical topics such as AAV manufacturing, cell and gene therapy, capacity management, quality assurance and control, regulatory compliance, operational excellence, and supply chain and logistics. Network with fellow biopharma leaders and connect with leading solution providers as we uncover strategies to maximize efficiency and ensure compliance within the biomanufacturing space.
The PCI Pharma team will be available to discuss how our biomanufacturing services and digital technologies will support your outsourcing questions and needs.
For more information or to register for this event, please see the event website
Details:
Event: American Biomanufacturing Summit 2026
Date: 14-15 Apr 2026
Where: Hyatt Regency San Francisco Airport
Country: USA
